Research

More Research Stories

Nurse practitioners fill gap by providing timely help in recording end-of-life treatment wishes

October 21, 2016
​Not all states allow nurse practitioners to make a patient’s treatment wishes part of their medical record, yet a six-year study concludes that they can improve seriously ill patients’ access to advance-care planning. Nurse practitioners often serve as the primary care provider or a member of the team caring for patients in the last months of their lives when they are most likely to seek end-of-life treatment counseling.

Fiscal Year 2016 achievements in technology transfer, business development

October 13, 2016
For 11 years, TTBD has hosted an award ceremony to celebrate university accomplishments and recognize OHSU employees who’ve made significant contributions to innovation, entrepreneurship, industry partnership, patenting, and technology commercialization. Following are highlights from last night’s 2016 TTBD Awards Ceremony.

Doernbecher researchers awarded more than $9 million to fight Fanconi anemia

By Tracy Brawley October 10, 2016
Thanks to a $9.9 million grant from the National Heart, Lung, and Blood Institute, a team led by Markus Grompe, M.D., director of the Oregon Stem Cell Center at OHSU and the Papé Family Pediatric Research Institute at OHSU Doernbecher Children’s Hospital, will work to understand human response to novel drug treatments that have shown promise in FA-positive animal models.

Targeted drug tames atopic eczema in Phase III trials

October 03, 2016
A drug that blocks the chemical messengers that are overactive in allergic reactions proved effective in clearing or reducing symptoms caused by atopic eczema, based on results from an international Phase III clinical trial led by OHSU in Portland, Oregon.
See more stories